Establishment Labs Holdings Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Establishment Labs Holdings Inc. on December 8, 2021, with the earliest event reported on that same date. The Company is incorporated in the British Virgin Islands and its common shares trade on the NASDAQ Capital Market under the symbol "ESTA". The filing primarily addresses corporate governance changes, specifically the appointment of a new director and the adoption of a new indemnification agreement.
Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document focuses exclusively on corporate governance and legal agreements.
Material Changes
- Board Appointment: The Board appointed Leslie Gillin as a Class II director, effective immediately. Her term will last until the 2023 annual meeting of shareholders.
- Board Composition: The size of the Board of Directors was increased to nine (9) directors.
- Committee Assignments: Ms. Gillin was appointed to the Compensation Committee and the Nominating and Corporate Governance Committee.
- Compensation: Ms. Gillin will receive the Company's standard non-employee director cash and equity compensation as detailed in the April 14, 2021, Schedule 14A proxy statement.
- Indemnification Agreement: On December 9, 2021, the Board approved an amended and restated form of director and officer indemnification agreement. This new agreement replaces existing agreements and provides indemnification to the fullest extent permitted by British Virgin Islands law, including rights to advancement of expenses.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding business operations. The primary risk disclosure relates to the legal framework of the new indemnification agreement, which is subject to exceptions under applicable laws. The Company confirmed there are no undisclosed arrangements or material interests regarding Ms. Gillin's appointment.
Key Facts for Investor Verification
- Verify the specific terms of the "standard non-employee director cash and equity compensation" referenced in the April 14, 2021, Schedule 14A proxy statement.
- Review the full text of the new Indemnification Agreement filed as Exhibit 10.1 to understand the scope of liability protection and expense advancement rights.
- Confirm the total number of directors on the Board is now nine following the expansion.
- Note that the press release regarding this appointment (Exhibit 99.1) is not deemed "filed" for purposes of Section 18 of the Exchange Act.